Continuing Education Supporters

This activity is supported by educational grants from:

• Astellas and Seagen
• AstraZeneca
• AVEO Pharmaceuticals, Inc. (“AVEO Oncology”)
• BeiGene
• Coherus BioSciences
• Eisai
• Exact Sciences
• Fresenius Kabi USA, LLC
• Genentech, a member of the Roche Group
• GRAIL, LLC
• GSK
• Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC
• Lantheus
• Lilly
• Novartis
• NOVOCURE
• Olympus Corporation of the Americas
• Puma Biotechnology
• TerSera Therapeutics LLC.

This activity is supported by independent educational grants from:

• AbbVie
• Daiichi Sankyo
• Gilead Sciences, Inc.
• Incyte Corporation

This activity is supported by medical education grants from:

• Exelixis, Inc.
• Karyopharm Therapeutics

This project has been made possible in part by a grant from:

• Varian Medical Systems, a Siemens Healthineers company /Global Medical Education Grant Program

This activity has been supported by an unrestricted educational grant from:

• GE HealthCare, Pharmaceutical Diagnostics

This activity is supported by educational funding provided by:

• Amgen

This activity is supported through an independent medical education grant from:

• Merck & Co., Inc.

This activity is supported by a grant from:

• Pfizer Inc.